we designed a phase ii study to determine whether induction chemotherapy ( ct ) consisting of leucovorin , vincristine , methotrexate , doxorubicin , and cyclophosphamide ( lomac ) followed by high-dose intensification chemotherapy ( ict ) with cyclophosphamide , thiotepa , and autologous stem cell rescue ( ascr ) could increase the complete response ( cr ) rate and survival in women with stage iv breast cancer .
C0051817
lomac
C0010583
cyclophosphamide